ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

Completed

Conditions studied: Paroxysmal Atrial Fibrillation

In brief

The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.

Key facts

Study ID

NCT06526546

Run by

Boston Scientific Corporation

People needed

364

Starts

2024-10-31

Expected to finish

2025-12-08

Last updated by the study team

2026-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who meet all of the following criteria may be given consideration for inclusion in this clinical investigation.
• Subjects who were enrolled, randomized and treated for paroxysmal atrial fibrillation, classified as Modified Intention-to-Treat subjects, and completed the 12-Month Follow-Up in the FARAPULSE ADVENT Trial (CIP CS0934; NCT04612244).
• Subjects or legally authorized representatives who are willing and capable of providing informed consent.
• Subjects who are willing to comply with the protocol requirements.

You may not qualify if…

• There are no exclusion criteria for this study.

Where it is running

• Grandview Medical Center — Birmingham, Alabama, United States
• Banner University Medical Center Phoenix — Phoenix, Arizona, United States
• Mills Peninsula Health Services — Burlingame, California, United States
• Scripps Memorial Hospital — La Jolla, California, United States
• University of California, San Francisco — San Francisco, California, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Emory University Hospital — Atlanta, Georgia, United States
• St. Lukes Idaho Cardiology Associates — Boise, Idaho, United States
• Johns Hopkins Hospital — Baltimore, Maryland, United States
• Massachusetts General Hospital (MGH) — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• St. Luke's Hospital of Kansas City — Kansas City, Missouri, United States
• Nebraska Methodist Hospital — Omaha, Nebraska, United States
• Mount Sinai, Icahn School of Medicine — New York, New York, United States
• Northwell Health — New York, New York, United States
• Providence St. Vincent Medical Center — Portland, Oregon, United States
• Doylestown Hospital — Doylestown, Pennsylvania, United States
• Presbyterian University of Pennsylvania Medical Center — Philadelphia, Pennsylvania, United States
• Pinnacle Health at Harrisburg Hospital — Wormleysburg, Pennsylvania, United States
• Trident Medical Center — Charleston, South Carolina, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• St. Thomas Research Institute, LLC — Nashville, Tennessee, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• Texas Cardiac Arrhythmia Research — Austin, Texas, United States
• Virginia Commonwealth University Health System — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.